Lanean...
Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.
Ceftazidime has pharmacokinetic advantages for treatment of endophthalmitis caused by gram negative-organisms by intravenous administration. Additionally, its spectrum of coverage for these organisms and its relatively low toxicity after intraocular injection are favorable attributes. These studies...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
1993
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1298483/ https://ncbi.nlm.nih.gov/pubmed/8140706 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|